Bemotrizinol's Approval Prompts Five Questions Patients Will Ask
FDA approval of bemotrizinol sends dermatology clinics a wave of patient questions. AJMC lays out five clinicians should be ready to answer.
Topic
Patient Counseling
Topic
Patient Counseling
Stanford Medicine Weighs In on Red Light Therapy Evidence
Stanford Medicine publishes a science review of red light therapy, giving dermatologists a citable anchor for counseling patients…
Castor Oil for Hair Growth: What Dermatology Times' Mythbusters Says
Dermatology Times' Social Media Mythbusters series tackles the viral claim that castor oil grows hair — a question clinicians now…
Safety Group Flags Cancer Evidence Against Popular Unapproved Peptide
On October 13, 2026, the Partnership for Safe Medicines reported mounting evidence linking a popular unapproved peptide to cancer…
Skin Cancer Foundation Releases Sunscreen Safety Reference for Clinicians
The Skin Cancer Foundation has published "Sunscreen Safety: The Facts," a reference resource on ultraviolet protection for clinic…
Dermatology Times Takes On the 'Botox in a Bottle' Myth
Dermatology Times' Social Media Mythbusters column targets 'Botox in a bottle' — topical products marketed as needle-free alterna…
Sorting Cosmeceutical Claims: A Field Guide for Dermatologists
HCPLive's new piece on skincare and cosmeceutical claims pushes dermatologists to grade products by active, concentration, endpoi…
Melanoma Diagnosed After Gym-Sourced Tanning Peptide Use
A man who injected a gym-bought tanning peptide has been diagnosed with melanoma — a case that revives long-standing warnings abo…
HS Biologics Need Time to Work, Jenny Hsiao, M.D., Says
At Fall Clinical Derm 2026, Jenny Hsiao, M.D., told clinicians that hidradenitis suppurativa biologics need adequate time to work…
Lebanese Study: Medical Students Know Sun Risks, Burn Anyway
Lebanese research on medical students finds expert-level UV knowledge coexists with sunburn, exposing a behavioral gap with direc…